DEHP
Use of DEHP-Containing Medical Products and Urinary Levels of MEHP in Neonatal Intensive Care Unit Infants
Exposure to DEHP Among Premature Neonates in a Neonatal Intensive Care Unit
This study provides the first quantitative evidence confirming that newborns who undergo intensive therapeutic medical interventions are exposed to higher concentrations of DEHP than the general population.
DEHP Exposures During the Medical Care of Infants - A Cause for Concern
Neonates and infants who receive medical care that includes the use of plasticized PVC products may easily be exposed to DEHP at levels that are in excess of the no observed adverse effect level (NOAEL) in animal tests. For some medical therapies, these exposures also exceed the FDA-derived “tolerable intake” (TI).
PVC Medical Devices Containing the Plasticizer DEHP - Guidelines for an Audit
Use this fact sheet to start PVC/DEHP audit in your hospital.
Decrease in Anogenital Distance among Male Infants with Prenatal Phthalate Exposure
Case Study: PVC and DEHP in Neonatal Intensive Care Units - Kaiser Permanente
Case Study: Evergreen Hospital NICU Strives to Become DEHP- and PVC-free
Case Study: Lucile Packard NICU Makes Major Strides to Remove DEHP
Case Study: John Muir Medical Center NICU is proudly DEHP-free
Páginas
- « primera
- ‹ anterior
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- siguiente ›
- última »